Extracellular ATP mediates mast cell-dependent intestinal inflammation through P2X7 purinoceptors

Nature Communications

Volumn 3, Issue , 2012, Pages

  Kurashima, Yosuke ^a,b,c   Amiya, Takeaki ^a,c   Nochi, Tomonori ^a   Fujisawa, Kumiko ^a,c   Haraguchi, Takeshi ^a   Iba, Hideo ^a   Tsutsui, Hiroko ^d   Sato, Shintaro ^a,c   Nakajima, Sachiko ^e   Iijima, Hideki ^e   Kubo, Masato ^f,g   Kunisawa, Jun ^a   Kiyono, Hiroshi ^a,b,c  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d HYOGO COLLEGE OF MEDICINE   (Japan)

^e OSAKA UNIVERSITY   (Japan)

^f RIKEN YOKOHAMA INSTITUTE   (Japan)

^g TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIBODY; CHEMOKINE; LEUKOTRIENE; PURINERGIC P2X7 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE EXACERBATION; ENTERITIS; FEMALE; HOST SUSCEPTIBILITY; MAST CELL; MOUSE; NEUTROPHIL; NONHUMAN; SUSCEPTIBILITY WEIGHTED IMAGING; WILD TYPE;

ADENOSINE TRIPHOSPHATE; ANIMALS; CELLS, CULTURED; CROHN DISEASE; CYTOKINES; FEMALE; HUMANS; INTESTINES; MAST CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, PURINERGIC P2X7;

MUS;

EID: 84866990701     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms2023     Document Type: Article

References (55)

1. Abraham, C. & Cho, J. H. Inflammatory bowel disease. N Engl. J. Med. 361, 2066-2078 (2009).
2. Strober, W. & Fuss, I. J. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology 140, 1756-1767 (2011).
3. Alvarez-Errico, D., Lessmann, E. & Rivera, J. Adapters in the organization of mast cell signaling. Immunol. Rev. 232, 195-217 (2009).
4. Bischoff, S. C. Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data. Nat. Rev. Immunol. 7, 93-104 (2007). (Pubitemid 46174857)
5. Galli, S. J., Borregaard, N. & Wynn, T. A. Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat. Immunol. 12, 1035-1044 (2011).
6. He, S. H. Key role of mast cells and their major secretory products in inflammatory bowel disease. World J. Gastroenterol. 10, 309-318 (2004).
7. Surprenant, A. & North, R. A. Signaling at purinergic P2X receptors. Annu. Rev. Physiol. 71, 333-359 (2009).
8. Erlinge, D. P2Y receptors in health and disease. Adv. Pharmacol. 61, 417-439 (2011).
9. Wilhelm, K. et al. Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R. Nat. Med. 16, 1434-1438 (2010).
10. Weber, F. C. et al. Lack of the purinergic receptor P2X(7) results in resistance to contact hypersensitivity. J. Exp. Med. 207, 2609-2619 (2010).
11. Muller, T. et al. A potential role for P2X7R in allergic airway inflammation in mice and humans. Am. J. Respir. Cell Mol. Biol. 44, 456-464 (2011).
12. Sudo, N. et al. Extracellular ATP activates mast cells via a mechanism that is different from the activation induced by the cross-linking of Fc receptors. J. Immunol. 156, 3970-3979 (1996). (Pubitemid 26137684)
13. Furuno, T., Teshima, R., Kitani, S., Sawada, J. & Nakanishi, M. Surface expression of CD63 antigen (AD1 antigen) in P815 mastocytoma cells by transfected IgE receptors. Biochem. Biophys. Res. Commun. 219, 740-744 (1996). (Pubitemid 26106752)
14. Rijnierse, A., Koster, A. S., Nijkamp, F. P. & Kraneveld, A. D. Critical role for mast cells in the pathogenesis of 2,4-dinitrobenzene-induced murine colonic hypersensitivity reaction. J. Immunol. 176, 4375-4384 (2006). (Pubitemid 44264418)
15. Kaser, A., Zeissig, S. & Blumberg, R. S. Inflammatory bowel disease. Annu. Rev. Immunol. 28, 573-621 (2010).
16. Feyerabend, T. B. et al. Cre-mediated cell ablation contests mast cell contribution in models of antibody-and T cell-mediated autoimmunity. Immunity 35, 832-844 (2011).
17. Otsuka, A. et al. Requirement of interaction between mast cells and skin dendritic cells to establish contact hypersensitivity. PLoS One 6, e25538 (2011).
18. Sawaguchi, M. et al. Role of mast cells and basophils in IgE responses and in allergic airway hyperresponsiveness. J. Immunol. 188, 1809-1818 (2012).
19. Fiorucci, S. et al. Importance of innate immunity and collagen binding integrin α1β1 in TNBS-induced colitis. Immunity 17, 769-780 (2002). (Pubitemid 35477796)
20. Yoshimoto, T. & Nakanishi, K. Roles of IL-18 in basophils and mast cells. Allergol. Int. 55, 105-113 (2006). (Pubitemid 43973882)
21. Pastorelli, L. et al. Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis. Proc. Natl Acad. Sci. USA 107, 8017-8022 (2010).
22. Kurashima, Y. et al. Sphingosine 1-phosphate-mediated trafficking of pathogenic Th2 and mast cells for the control of food allergy. J. Immunol. 179, 1577-1585 (2007).
23. Nicke, A. et al. A functional P2X7 splice variant with an alternative transmembrane domain 1 escapes gene inactivation in P2X7 knock-out mice. J. Biol. Chem. 284, 25813-25822 (2009).
24. Smart, M. L. et al. P2X7 receptor cell surface expression and cytolytic pore formation are regulated by a distal C-terminal region. J. Biol. Chem. 278, 8853-8860 (2003). (Pubitemid 36800645)
25. Di Virgilio, F. Liaisons dangereuses: P2X7 and the inflammasome. Trends Pharmacol. Sci. 28, 465-472 (2007).
26. Mizutani, H., Schechter, N., Lazarus, G., Black, R. A. & Kupper, T. S. Rapid and specific conversion of precursor interleukin 1β (IL-1β) to an active IL-1 species by human mast cell chymase. J. Exp. Med. 174, 821-825 (1991).
27. Yegutkin, G. G. Nucleotide-and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade. Biochim. Biophys. Acta. 1783, 673-694 (2008).
28. Locovei, S., Bao, L. & Dahl, G. Pannexin 1 in erythrocytes: function without a gap. Proc. Natl Acad. Sci. USA 103, 7655-7659 (2006).
29. Kang, J. et al. Connexin 43 hemichannels are permeable to ATP. J. Neurosci. 28, 4702-4711 (2008).
30. Burrell, H. E. et al. Human keratinocytes release ATP and utilize three mechanisms for nucleotide interconversion at the cell surface. J. Biol. Chem. 280, 29667-29676 (2005). (Pubitemid 41177043)
31. Foger, N. et al. Differential regulation of mast cell degranulation versus cytokine secretion by the actin regulatory proteins Coronin1a and Coronin1b. J. Exp. Med. 208, 1777-1787 (2011).
32. Salamon, P. et al. Human mast cells release oncostatin M on contact with activated T cells: possible biologic relevance. J. Allergy Clin. Immunol. 121, 448-455 e5 (2008).
33. Bento, A. F. et al. The selective nonpeptide CXCR2 antagonist SB225002 ameliorates acute experimental colitis in mice. J. Leukoc. Biol. 84, 1213-1221 (2008).
34. Luo, M., Jones, S. M., Peters-Golden, M. & Brock, T. G. Nuclear localization of 5-lipoxygenase as a determinant of leukotriene B4 synthetic capacity. Proc. Natl Acad. Sci. USA 100, 12165-12170 (2003). (Pubitemid 37271532)
35. Nigrovic, P. A. et al. Genetic inversion in mast cell-deficient Wsh mice interrupts corin and manifests as hematopoietic and cardiac aberrancy. Am. J. Pathol. 173, 1693-1701 (2008).
36. Cesaro, A. et al. Amplification loop of the inflammatory process is induced by P2X7R activation in intestinal epithelial cells in response to neutrophil transepithelial migration. Am. J. Physiol. Gastrointest Liver Physiol. 299, G32-G42 (2010).
37. Schenk, U. et al. ATP inhibits the generation and function of regulatory T cells through the activation of purinergic P2X receptors. Sci. Signal 4, ra12 (2011).
38. Atarashi, K. et al. ATP drives lamina propria TH17 cell differentiation. Nature 455, 808-812 (2008).
39. Wareham, K., Vial, C., Wykes, R. C., Bradding, P. & Seward, E. P. Functional evidence for the expression of P2X1, P2X4 and P2X7 receptors in human lung mast cells. Br. J. Pharmacol. 157, 1215-1224 (2009).
40. Piccini, A. et al. ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1β and IL-18 secretion in an autocrine way. Proc. Natl Acad. Sci. USA 105, 8067-8072 (2008). (Pubitemid 351904709)
41. Friedman, D. J. et al. From the Cover: CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease. Proc. Natl Acad. Sci. USA 106, 16788-16793 (2009).
42. Feng, C., Mery, A. G., Beller, E. M., Favot, C. & Boyce, J. A. Adenine nucleotides inhibit cytokine generation by human mast cells through a Gs-coupled receptor. J. Immunol. 173, 7539-7547 (2004). (Pubitemid 39628195)
43. Louis, N. A. et al. Control of IFN-αA by CD73: implications for mucosal inflammation. J. Immunol. 180, 4246-4255 (2008).
44. Rijnierse, A., Koster, A. S., Nijkamp, F. P. & Kraneveld, A. D. TNF-α is crucial for the development of mast cell-dependent colitis in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 291, G969-G976 (2006). (Pubitemid 44772023)
45. Cuzzocrea, S. et al. 5-Lipoxygenase modulates colitis through the regulation of adhesion molecule expression and neutrophil migration. Lab. Invest. 85, 808-822 (2005). (Pubitemid 40799710)
46. Waddell, A. et al. Colonic eosinophilic inflammation in experimental colitis is mediated by Ly6Chigh CCR2+ inflammatory monocyte/macrophage-derived CCL11. J. Immunol. 186, 5993-6003 (2011).
47. Chen, Y. et al. Purinergic signaling: a fundamental mechanism in neutrophil activation. Sci. Signal 3, ra45 (2010).
48. Kuida, K. et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme. Science 267, 2000-2003 (1995).
49. Tsai, M., Grimbaldeston, M. A., Yu, M., Tam, S. Y. & Galli, S. J. Using mast cell knock-in mice to analyze the roles of mast cells in allergic responses in vivo. Chem. Immunol. Allergy 87, 179-197 (2005). (Pubitemid 43093188)
50. Wirtz, S., Neufert, C., Weigmann, B. & Neurath, M. F. Chemically induced mouse models of intestinal inflammation. Nat. Protoc. 2, 541-546 (2007). (Pubitemid 47040018)
51. Ransford, G. A. et al. Pannexin 1 contributes to ATP release in airway epithelia. Am. J. Respir. Cell Mol. Biol. 41, 525-534 (2009).
52. Kunisawa, J. et al. Sphingosine 1-phosphate dependence in the regulation of lymphocyte trafficking to the gut epithelium. J. Exp. Med. 204, 2335-2348 (2007). (Pubitemid 47529320)
53. Nochi, T. et al. A novel M cell-specific carbohydrate-targeted mucosal vaccine effectively induces antigen-specific immune responses. J. Exp. Med. 204, 2789-2796 (2007). (Pubitemid 350179549)
54. Yu, J. Y., DeRuiter, S. L. & Turner, D. L. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc. Natl Acad. Sci. USA 99, 6047-6052 (2002). (Pubitemid 34493262)
55. Haraguchi, T., Ozaki, Y. & Iba, H. Vectors expressing efficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells. Nucleic Acids Res. 37, e43 (2009).